H5N1 Idaho Becomes the National Epicenter with Eighty-Six Herds Infected
Four south-central counties, 59 active quarantines, and a cattle-to-cattle transmission narrative the state veterinarian has stopped hedging.
Nora Whitfield
Bureau: Chicago
Regeneron Prints the First Gene Therapy Approval for a Genetic Hearing Loss
Twenty children, sixteen improved, five achieved normal hearing — one gene therapy, one infusion, one first-ever FDA approval reshaping pediatric otolaryngology.
Alzheimer Day Nine Leaves FDA and CMS Silence as the De Facto Policy
Nine days after the Cochrane critique, no U.S. regulator has reset guidance, making non-response functionally indistinguishable from policy.
Helium Day Twelve Hardens the Radiology Policy Stack
Day 12 keeps the same shortage math but raises the policy temperature as radiology journals now ask Washington to treat helium like a strategic material.
Measles Day Eight Holds at 1748 Across 33 Jurisdictions
The federal milestone number still sits at 1,748 cases across 33 jurisdictions, while California has already surpassed its full 2025 case count.
MMWR Date Watch Extends as CDC Cadence Keeps Thinning
Friday adds no special catch-up signal from MMWR, extending the publication-cadence concern the paper has tracked all week.
Boston Marathon Day Six Keeps the 80 Plus Data Question Open
The 80-plus cohort count is public, but age-stratified medical outcomes are still not, extending transparency pressure into Day Six.
LaGuardia Preliminary Locks the Stop Stop Stop Timeline
The NTSB preliminary report adds radio language and exact timestamps, turning a known near-instant conflict into a fully legible systems failure.
GLP One Day Twenty Three Keeps the FDA Enforcement Ramp Intact
The warning-letter stack still sits near thirty and the compounding boundary has not softened, keeping pressure on gray-market GLP-1 channels.